K. Thomson

发表

Prevalence of Newer β-Lactamases in Gram-Negative Clinical Isolates Collected in the United States from 2001 to 2002

Wonkeun Song, A. Hossain, E. S. Moland, 2006, Journal of Clinical Microbiology.

b-Lactamases and Detection of b-Lactam Resistance in Enterobacterspp.

J. Pitout, E. S. Moland, K. Thomson, 1997 .

Beta-lactamases and detection of beta-lactam resistance in Enterobacter spp

S. R. Fitzsimmons, J. Pitout, E. S. Moland, 1997, Antimicrobial agents and chemotherapy.

Plasmid-Mediated Resistance to Expanded-Spectrum Cephalosporins among Enterobacter aerogenesStrains

P. Coudron, J. Pitout, N. Hanson, 1998, Antimicrobial Agents and Chemotherapy.

USA resistance patterns among UTI pathogens.

K. Thomson, C. Sanders, W. Sanders, 1994, The Journal of antimicrobial chemotherapy.

AmpC Disk Test for Detection of Plasmid-Mediated AmpC β-Lactamases in Enterobacteriaceae Lacking Chromosomal AmpC β-Lactamases

E. S. Moland, J. Black, K. Thomson, 2005, Journal of Clinical Microbiology.

Cefditoren: In Vitro Activity Against Respiratory Pathogens and β-Lactamase Stability

E. S. Moland, J. Black, K. Thomson, 2004 .

Discovery of CTX-M-Like Extended-Spectrum β-Lactamases in Escherichia coli Isolates from Five U.S. States

A. Hossain, E. S. Moland, N. Hanson, 2003, Antimicrobial Agents and Chemotherapy.

NmcA Carbapenem-hydrolyzing Enzyme in Enterobacter cloacae in North America

S. Swanzy, T. Fritsche, S. Juretschko, 2003, Emerging infectious diseases.

Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests

K. Thomson, C. Sanders, 1992, Antimicrobial Agents and Chemotherapy.

New variant of TEM-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilis

T. Palzkill, W. Huang, E. S. Moland, 1995, Antimicrobial agents and chemotherapy.

β-Lactamases Responsible for Resistance to Expanded-Spectrum Cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis Isolates Recovered in South Africa

J. Pitout, E. S. Moland, N. Hanson, 1998, Antimicrobial Agents and Chemotherapy.

Use of Microdilution Panels with and without β-Lactamase Inhibitors as a Phenotypic Test for β-Lactamase Production among Escherichia coli, Klebsiella spp.,Enterobacter spp., Citrobacter freundii, andSerratia marcescens

E. S. Moland, K. Thomson, C. Sanders, 1999, Antimicrobial Agents and Chemotherapy.

Comparison of the Carba NP, Modified Carba NP, and Updated Rosco Neo-Rapid Carb Kit Tests for Carbapenemase Detection

Gina K. Thomson, J. Snyder, K. Thomson, 2015, Journal of Clinical Microbiology.

Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium.

E. S. Moland, K. Thomson, E. Smith Moland, 2000, Microbes and infection.

Use of β-Lactamase Inhibitors in Disk Tests To Detect Plasmid-Mediated AmpC β-Lactamases

J. Pitout, J. Black, K. Thomson, 2004, Journal of Clinical Microbiology.

Multicenter, Prospective Validation of a Phenotypic Algorithm to Guide Carbapenemase Testing in Carbapenem-Resistant Pseudomonas aeruginosa Using the ERACE-PA Global Surveillance Program

Y. Carmeli, L. Bourassa, H. Seifert, 2021, Open forum infectious diseases.

Activity of Cefepime-Zidebactam against Multidrug-Resistant (MDR) Gram-Negative Pathogens

Gina K. Thomson, J. Snyder, K. Thomson, 2019, Antibiotics.

The Immaculate Carbapenemase Study

K. Thomson, 2017, Journal of Clinical Microbiology.

An Improved Extended-Spectrum-β-Lactamase Detection Test Utilizing Aztreonam plus Clavulanate

Gina K. Thomson, K. Thomson, M. Ayaz, 2017, Journal of Clinical Microbiology.

In vitro development of resistance to DX-619 and other quinolones in enterococci.

N. Hanson, J. Black, K. Thomson, 2006, The Journal of antimicrobial chemotherapy.

Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 beta-lactamases.

A. Hossain, E. S. Moland, N. Hanson, 2002, The Journal of antimicrobial chemotherapy.

βlasEN: Microdilution Panel for Identifying β-Lactamases Present in Isolates of Enterobacteriaceae

B. Zimmer, E. S. Moland, K. Thomson, 2002, Journal of Clinical Microbiology.

Selective ceftazidime resistance in Escherichia coli: association with changes in outer membrane protein.

J. Bakken, K. Thomson, C. Sanders, 1987, The Journal of infectious diseases.

Activity of Tedizolid (TR-700) against Well-Characterized Methicillin-Resistant Staphylococcus aureus Strains of Diverse Epidemiological Origins

R. Goering, K. Thomson, 2013, Antimicrobial Agents and Chemotherapy.

CPO Complete, a novel test for fast, accurate phenotypic detection and classification of carbapenemases

Gina K. Thomson, K. Thomson, Sameh Abdelghani, 2019, bioRxiv.

In Vitro Studies with DQ-113 and Comparison Fluoroquinolones To Determine Propensities To Select Resistance in Gram-Positive Cocci

A. Hossain, E. S. Moland, N. Hanson, 2007, Antimicrobial Agents and Chemotherapy.

High-level resistance to cefotaxime and ceftazidime in Klebsiella pneumoniae isolates from Cleveland, Ohio

J. Washington, K. Thomson, C. Sanders, 1991, Antimicrobial Agents and Chemotherapy.

The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa

Y. Carmeli, C. Burnham, L. Bourassa, 2021, European Journal of Clinical Microbiology & Infectious Diseases.

Beta-lactamases and detection of beta-lactam resistance in Enterobacter spp.

S. R. Fitzsimmons, J. Pitout, E. S. Moland, 1997, Antimicrobial agents and chemotherapy.

In Vitro Activity of Cefdinir and Comparison Agents Against β-Lactamase-Producing Pathogens

Wonkeun Song, E. S. Moland, K. Thomson, 2005 .

Activity of oral agents against pediatric isolates of Streptococcus pneumoniae.

E. S. Moland, J. Black, K. Thomson, 2001, Diagnostic microbiology and infectious disease.

Electron Microscopic Observations of Flavobacterium aquatile NCIB 8694 (= ATCC 11947) and Flavobacterium meningosepticum NCTC 10016 (= ATCC 13253)

T. McMeekin, C. Thomas, K. Thomson, 1981 .

In Vitro Activity of Tigecycline against Multidrug-Resistant Acinetobacter baumannii and Selection of Tigecycline-Amikacin Synergy

E. S. Moland, K. Thomson, D. Craft, 2008, Antimicrobial Agents and Chemotherapy.

Clinical efficacy of mesalamine in the treatment of the spondyloarthropathies.

B. Thomson, K. Thomson, G. Thomson, 2000, The Journal of rheumatology.

Controversies about extended-spectrum and AmpC beta-lactamases.

K. Thomson, 2001, Emerging infectious diseases.

Occurrence and Detection of AmpC Beta-Lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis Isolates at a Veterans Medical Center

P. Coudron, E. S. Moland, K. Thomson, 2000, Journal of Clinical Microbiology.

AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases.

E. S. Moland, J. Black, K. Thomson, 2005, Journal of clinical microbiology.

Evaluation of β-Lactamase Inhibitors in Disk Tests for Detection of Plasmid-Mediated AmpC β-Lactamases in Well-Characterized Clinical Strains of Klebsiella spp

J. Pitout, J. Black, K. Thomson, 2005, Journal of Clinical Microbiology.

Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatin.

C. Watanakunakorn, K. Thomson, A. Ehrhardt, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Minimizing quinolone resistance: are the new agents more or less likely to cause resistance?

K. Thomson, 2000, The Journal of antimicrobial chemotherapy.

IMP-27, a Unique Metallo-β-Lactamase Identified in Geographically Distinct Isolates of Proteus mirabilis

C. Geyer, Y. Ishii, E. S. Moland, 2016, Antimicrobial Agents and Chemotherapy.

Convenient Test Using a Combination of Chelating Agents for Detection of Metallo-β-Lactamases in the Clinical Laboratory

E. S. Moland, K. Thomson, S. Hong, 2007, Journal of Clinical Microbiology.

First Occurrence of a Pseudomonas aeruginosa Isolate in the United States Producing an IMP Metallo-β-Lactamase, IMP-18

A. Hossain, E. S. Moland, N. Hanson, 2006, Antimicrobial Agents and Chemotherapy.

Failure of Cefepime Therapy in Treatment of Klebsiella pneumoniae Bacteremia

Wonkeun Song, J. Jorgensen, E. S. Moland, 2005, Journal of Clinical Microbiology.

Activity of faropenem against resistant isolates of Streptococcus pneumoniae.

E. S. Moland, J. Black, K. Thomson, 2001, Diagnostic microbiology and infectious disease.

Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae

S. Block, K. Thomson, C. Sanders, 1997, Antimicrobial agents and chemotherapy.

In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance.

S. Block, K. Thomson, C. Sanders, 1999, The Journal of antimicrobial chemotherapy.

Agar antibiotic levels in three-dimensional susceptibility testing

K. Thomson, J. Carpenter, S. Aldous, 1985 .

[Evaluation of the E-test: comparison of E-test and microbroth dilution method in azole antifungal susceptibility test].

Y. Tanaka, H. Komaki, K. Yazawa, 1998, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology.

Cefepime, Piperacillin-Tazobactam, and the Inoculum Effect in Tests with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae

Kenneth S. Thomson, E. S. Moland, K. Thomson, 2001, Antimicrobial Agents and Chemotherapy.

Detection of Extended-Spectrum β-Lactamases in Members of the Family Enterobacteriaceae: Comparison of the Double-Disk and Three-Dimensional Tests

K. Thomson, C. Sanders, Creighton, 1992, Antimicrobial Agents and Chemotherapy.

3-Dimensional susceptibility testing of β-lactam antibiotics

K. Thomson, T. J. Regan, Z. A. Mejglo, 1984 .

Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates.

R. Goering, Judith A. Johnson, A. Hossain, 2003, The Journal of antimicrobial chemotherapy.

Klebsiella pneumoniae isolate producing at least eight different beta-lactamases, including AmpC and KPC beta-lactamases.

E. S. Moland, N. Hanson, K. Thomson, 2007, Antimicrobial agents and chemotherapy.

Klebsiella pneumoniae Isolate Producing at Least Eight Different β-Lactamases, Including AmpC and KPC β-Lactamases

E. S. Moland, N. Hanson, K. Thomson, 2006, Antimicrobial Agents and Chemotherapy.

Escherichia coli: development of carbapenem resistance during therapy.

Baha Abdalhamid, B. Abdalhamid, E. S. Moland, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Occurrence of Newer β-Lactamases in Klebsiella pneumoniae Isolates from 24 U.S. Hospitals

E. S. Moland, N. Hanson, J. Black, 2002, Antimicrobial Agents and Chemotherapy.

Evaluation of beta-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC beta-lactamases in well-characterized clinical strains of Klebsiella spp.

J. Pitout, J. Black, K. Thomson, 2005, Journal of clinical microbiology.

Ability of the VITEK 2 Advanced Expert System To Identify β-Lactam Phenotypes in Isolates of Enterobacteriaceae andPseudomonas aeruginosa

Kenneth S. Thomson, M. Peyret, E. S. Moland, 2000, Journal of Clinical Microbiology.

Ceftazidime resistance in Hafnia alvei

J. Washington, K. Thomson, C. Sanders, 1993, Antimicrobial Agents and Chemotherapy.

Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase Issues

Kenneth S. Thomson, K. Thomson, Kenneth S. Thomson, 2010, Journal of Clinical Microbiology.

COMMENTARY Extended-Spectrum- (cid:1) -Lactamase, AmpC, and Carbapenemase Issues (cid:1)

K. Thomson, 2010 .

Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.

E. S. Moland, N. Hanson, J. Black, 2002, Antimicrobial agents and chemotherapy.

Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpC.

R. Penn, E. S. Moland, N. Hanson, 1999, The Journal of antimicrobial chemotherapy.

Lowering of third generation cephalosporin breakpoints.

K. Thomson, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Production of KPC-2 Alone Does Not Always Result in β-Lactam MICs Representing Resistance in Gram-Negative Pathogens

N. Hanson, K. Thomson, P. Lister, 2012, Journal of Clinical Microbiology.

Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.

E. S. Moland, K. Thomson, C. Sanders, 1999, The Journal of antimicrobial chemotherapy.

In Vitro Activities of DX-619 and Comparison Quinolones against Gram-Positive Cocci

E. S. Moland, J. Black, K. Thomson, 2006, Antimicrobial Agents and Chemotherapy.

Fluoroquinolone resistance in staphylococci: new challenges.

K. Thomson, C. Sanders, W. Sanders, 1995, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

Chronic strongyloidiasis in Tasmanian veterans--clinical diagnosis by the use of a screening index.

R. Byard, K. Thomson, J. Goldsmid, 1989, Australian and New Zealand Journal of Medicine.

STRONGYLOIDIASIS IN EX–PRISONERS OF WAR

K. Thomson, J. Goldsmid, J. Claxton, 1980, The Medical journal of Australia.

Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamases.

K. Thomson, C. Sanders, W. Sanders, 1989, The Journal of antimicrobial chemotherapy.

Identification of Gram-Negative Bacteria and Genetic Resistance Determinants from Positive Blood Culture Broths by Use of the Verigene Gram-Negative Blood Culture Multiplex Microarray-Based Molecular Assay

R. Thomson,, K. Carroll, P. Pancholi, 2015, Journal of Clinical Microbiology.

r-Lactamase Production in Members of the Family Enterobacteriaceae and Resistance to P-Lactam-Enzyme Inhibitor Combinations

K. Thomson, C. Sanders, W. Sanders, 2003 .

Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations

K. Thomson, C. Sanders, W. Sanders, 1990, Antimicrobial Agents and Chemotherapy.

Potential Impact of the VITEK 2 System and the Advanced Expert System on the Clinical Laboratory of a University-Based Hospital

Kenneth S. Thomson, M. Peyret, E. S. Moland, 2001, Journal of Clinical Microbiology.

3-Dimensional susceptibility testing of beta-lactam antibiotics.

K. Thomson, T. J. Regan, Z. A. Mejglo, 1984, Journal of Antimicrobial Chemotherapy.

Newer β-Lactamases: Clinical and Laboratory Implications, Part I*

E. S. Moland, K. Thomson, S. Hong, 2008 .

Can Results Obtained with Commercially Available MicroScan Microdilution Panels Serve as an Indicator of β-Lactamase Production among Escherichia coli andKlebsiella Isolates with Hidden Resistance to ExpandedSpectrum Cephalosporins and Aztreonam?

Kenneth S. Thomson, E. S. Moland, K. Thomson, 1998, Journal of Clinical Microbiology.

Comparison of Phoenix and VITEK 2 Extended-Spectrum-β-Lactamase Detection Tests for Analysis of Escherichia coli and Klebsiella Isolates with Well-Characterized β-Lactamases

Kenneth S. Thomson, Ellen S. Moland, E. S. Moland, 2007, Journal of Clinical Microbiology.

Plasmid-Mediated Carbapenem-Hydrolyzing Enzyme KPC-2 in an Enterobacter sp

M. Ferraro, R. Goering, A. Hossain, 2004, Antimicrobial Agents and Chemotherapy.

Extended-spectrum beta-lactamases of Enterobacteriaceae.

E. S. Moland, K. Thomson, 1994, The Journal of antimicrobial chemotherapy.

Indirect Tris-EDTA Disk Testing Using Imipenem and Meropenem for Detection of OXA-48 Carbapenemase Production

Gina K. Thomson, J. Snyder, K. Thomson, 2015, Journal of Clinical Microbiology.

Clinical Implications and Detection of Newer ß-lactamases

K. Thomson, 2008 .

Novel plasmid-mediated beta-lactamases in enterobacteriaceae: emerging problems for new beta-lactam antibiotics.

K. Thomson, C. Sanders, A. M. Prevan, 1996, Current clinical topics in infectious diseases.

Kinetics Study of KPC-3, a Plasmid-Encoded Class A Carbapenem-Hydrolyzing β-Lactamase

Y. Ishii, K. Yamaguchi, E. S. Moland, 2005, Antimicrobial Agents and Chemotherapy.

A simple and reliable method to screen isolates of Escherichia coli and Klebsiella pneumoniae for the production of TEM- and SHV-derived extended-spectrum β-lactamases

K. Thomson, C. Sanders, 1997 .

Automated preparation for identification and antimicrobial susceptibility testing: evaluation of a research use only prototype, the BD Kiestra IdentifA/SusceptA system

James W. Snyder, Kenneth S. Thomson, Gina K. Thomson, 2020 .

Digital imaging for reading of direct rapid antibiotic susceptibility tests from positive blood cultures

Gina K. Thomson, J. Snyder, K. Thomson, 2021, European Journal of Clinical Microbiology & Infectious Diseases.

Double-Carbapenem Therapy Not Proven To Be More Active than Carbapenem Monotherapy against KPC-Positive Klebsiella pneumoniae

K. Thomson, 2012, Antimicrobial Agents and Chemotherapy.

Mutational Resistance to Quinolones in Staphylococci

E. S. Moland, K. Thomson, C. Sanders, 1999, Drugs.

Cefdinir: an oral alternative to parenteral cephems.

E. S. Moland, K. Thomson, A. Chatterjee, 2005, Diagnostic microbiology and infectious disease.

Clonality and Resistome Analysis of KPC-Producing Klebsiella pneumoniae Strain Isolated in Korea Using Whole Genome Sequencing

J. Chun, Bong-Soo Kim, D. Yong, 2014, BioMed research international.

High-Stringency Evaluation of the Automated BD Phoenix CPO Detect and Rapidec Carba NP Tests for Detection and Classification of Carbapenemases

Gina K. Thomson, S. Kircher, K. Thomson, 2017, Journal of Clinical Microbiology.

Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam–β-Lactamase Inhibitor Combinations

Gina K. Thomson, J. Snyder, C. McElheny, 2015, Journal of Clinical Microbiology.

Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae : Implications for Newer (cid:2) -Lactam– (cid:2) -Lactamase Inhibitor Combinations

Gina K. Thomson, J. Snyder, C. McElheny, 2016 .

Rapid identification from rectal swabs of the clinically most relevant carbapenemase genes from gram-negative bacteria using the BD MAX Check-Points CPO Assay.

Gina K. Thomson, N. Ledeboer, R. Cantón, 2021, Diagnostic microbiology and infectious disease.

Dissemination and Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Collected in Puerto Rico Medical Center Hospitals during a 1-Year Period

Iraida E. Robledo, R. Goering, E. Aquino, 2011 .

Dissociated resistance among fluoroquinolones

K. Thomson, C. Sanders, 1994, Antimicrobial Agents and Chemotherapy.

A Novel Topical Combination Ointment with Antimicrobial Activity against Methicillin-Resistant Staphylococcus aureus, Gram-Negative Superbugs, Yeasts, and Dermatophytic Fungi

Gina K. Thomson, K. Thomson, A. Deeb, 2016, Current therapeutic research, clinical and experimental.